Revista de Management Comparat International (Oct 2015)
Research on the Pharmaceutical Market in Europe and Romania
Abstract
The objectives of the present study were to analyze and present the pharmaceutical market in Romania and Europe, in particular from the following five European countries, the EU-5 (France, Germany, Italy, UK, and Spain). They followed the issues about the market of medicines, the medicines distributors and producers, exploring the availability and consumption of certain types of products, such as original and generic medicines or the medicines subject to prescription. Another objective was to highlight the pharmaceutical market predictions for the coming years. For conducting the study, "desk research" and predictive methods were primarily used, studying the files of pharmaceutical companies, national statistics, government reports, company analysis published data and market studies, as well as information from the media. Highlighting achievements include pharmaceuticals market values, production of medicines in Europe and in Romania in recent years, the major producers and distributors, the best-selling, or the most expensive drugs in Romania. Forecasts show that by 2018 there will not be major changes in the drug market, emphasising that this economy is relatively stable, with no significant fluctuations from year to year.